Toshi A. Furukawa

ORCID: 0000-0003-2159-3776
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Mental Health Research Topics
  • Treatment of Major Depression
  • Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Meta-analysis and systematic reviews
  • Child and Adolescent Psychosocial and Emotional Development
  • Schizophrenia research and treatment
  • Mental Health Treatment and Access
  • Health Systems, Economic Evaluations, Quality of Life
  • Digital Mental Health Interventions
  • Electroconvulsive Therapy Studies
  • Bipolar Disorder and Treatment
  • Functional Brain Connectivity Studies
  • Statistical Methods in Clinical Trials
  • Dementia and Cognitive Impairment Research
  • Tryptophan and brain disorders
  • Maternal Mental Health During Pregnancy and Postpartum
  • Health disparities and outcomes
  • Cancer survivorship and care
  • Family Support in Illness
  • Obsessive-Compulsive Spectrum Disorders
  • Attention Deficit Hyperactivity Disorder
  • Delphi Technique in Research
  • Childhood Cancer Survivors' Quality of Life
  • Psychosomatic Disorders and Their Treatments
  • Pain Management and Placebo Effect

Kyoto University
2016-2025

University of Oxford
2018-2024

RELX Group (Netherlands)
2024

Tokai University
2000-2023

Creative Commons
2023

University of Arizona
2023

University of Bern
2023

Oxford BioMedica (United Kingdom)
2023

University of California, Los Angeles
2021-2023

Shizuoka General Hospital
2023

Background. Two new screening scales for psychological distress, the K6 and K10, have been developed but their relative efficiency has not evaluated in comparison with existing scales. Method. The Australian National Survey of Mental Health Well-Being, a nationally representative household survey, administered WHO Composite International Diagnostic Interview (CIDI) to assess 30-day DSM-IV disorders. K10 were also along General Questionnaire (GHQ-12), current de facto standard mental health...

10.1017/s0033291702006700 article EN Psychological Medicine 2003-02-01

Abstract Two new screening scales for psychological distress, the K6 and K10, have been developed using item response theory shown to outperform existing screeners in English. We their Japanese versions standard backtranslaton method included them World Mental Health Survey Japan (WMH‐J), which is a psychiatric epidemiologic study conducted seven communities across with 2436 participants. The WMH‐J used WMH Initiative version of Composite International Diagnostic Interview (CIDI) assess...

10.1002/mpr.257 article EN International Journal of Methods in Psychiatric Research 2008-09-01

Data are reported on the background and performance of K6 screening scale for serious mental illness (SMI) in World Health Organization (WHO) Mental (WMH) surveys. The is a six-item developed to provide brief valid screen Diagnostic Statistical Manual Disorders 4th edition (DSM-IV) SMI based criteria US ADAMHA Reorganization Act. Although methodological studies have documented good validity number countries, optimal scoring rules never been proposed. Such presented here analysis data...

10.1002/mpr.310 article EN International Journal of Methods in Psychiatric Research 2010-05-31

IMPORTANCECognitive behavior therapy (CBT) has been shown to be effective in the treatment of acute depression.However, whether CBT can effectively delivered individual, group, telephone-administered, guided self-help, and unguided self-help formats remains unclear.OBJECTIVE To examine most delivery format for via a network meta-analysis.

10.1001/jamapsychiatry.2019.0268 article EN JAMA Psychiatry 2019-04-17

No network meta-analysis has examined the relative effects of psychotherapies, pharmacotherapies and their combination in treatment adult depression, while this is a very important clinical issue. We conducted systematic searches bibliographical databases to identify randomized trials which psychotherapy pharmacotherapy for acute or long-term depression were compared with each other, was either one alone. The main outcome response (50% improvement between baseline endpoint). Remission...

10.1002/wps.20701 article EN World Psychiatry 2020-01-10

Dose equivalence of antidepressants is critically important for clinical practice and research. There are several methods to define calculate dose but antidepressants, only daily defined consensus have been applied date. The purpose the present study examine by a less arbitrary more systematic method.We used data from all randomized, double-blind, flexible-dose trials comparing fluoxetine or paroxetine as standard drugs with any other active monotherapy in acute phase treatment unipolar...

10.1016/j.jad.2015.03.021 article EN cc-by-nc-nd Journal of Affective Disorders 2015-04-05

To examine empirically whether the mean difference (MD) or standardised (SMD) is more generalizable and statistically powerful in meta-analyses of continuous outcomes when same unit used. From all Cochrane Database (March 2013), we identified systematic reviews that combined 3 randomised controlled trials (RCT) using outcome. Generalizability was assessed I-squared (I2) percentage agreement. The agreement calculated by comparing MD SMD each RCT with corresponding from meta-analysis other...

10.1186/1471-2288-14-30 article EN cc-by BMC Medical Research Methodology 2014-02-21
Coming Soon ...